Invicta Diagnos.

: INVICTA · Healthcare Service Provider

52W Range₹58 ₹105

Limited coverage

We are not actively covering this company or have limited coverage today. Click to request coverage.

Snapshot

Unlock Invicta Diagnos.'s vital signs

Growth · Profitability · Valuation · Strength · Conviction

Company Overview

Business

Invicta Diagnostic Limited is a healthcare service provider specialising in radiology and pathology solutions. The company operates a diagnostic chain within the Mumbai Metropolitan Region.

Business Model

The company operates on a hub-and-spoke model, leveraging a centralised laboratory supported by seven diagnostic centres to deliver diagnostic services.

  • Diagnostic Centres:7
  • Centralised Laboratories:1

Growth Outlook

Growth is expected to be driven by the expansion of its diagnostic network and the optimisation of its hub-and-spoke operational model within the Mumbai Metropolitan Region.

Key Risks

  • Geographic Concentration. The company's operations are heavily concentrated in the Mumbai Metropolitan Region, exposing it to localised economic and regulatory risks.
  • Intense Competition. The diagnostic services sector in India is highly fragmented and competitive, which may exert pressure on pricing and margins.
  • Regulatory Compliance. Healthcare providers are subject to stringent quality standards and evolving government regulations regarding medical testing and diagnostic facilities.

Start your research today

Unlock AI insights, financials, peers and live data on Invicta Diagnos. and 5,000+ companies — free.

Start your research

Peers · Healthcare Service Provider

CompanyMkt CapP/EEV/EBITDARev Gr YoYEBITDA MgnROEROCE1Y Return
Invicta Diagnos.INVICTA
₹88 Cr30.2%
Krsnaa Diagnostics Ltd.KRSNAA
₹1,830 Cr18.768.8010.2%32.5%10.5%13.3%-28.5%
Suraksha Diagnostic Ltd.SURAKSHA
₹1,772 Cr48.6016.7322.5%32.7%15.8%18.6%+14.0%
3B BlackBio Dx Ltd3BBLACKBIO
₹1,237 Cr20.6114.5941.9%58.0%21.2%26.3%+0.5%
One Global Service Provider LimitedONEGLOBAL
₹1,068 Cr19.0%+114.9%
Gaudium IVF and Women Health LimitedGAUDIUMIVF
₹886 Cr36.0%

As of Mar 2026

Financials